Baudax Bio, Inc. (BXRXQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Baudax Bio Total Assets (Quarterly)
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 20.58M |
| June 30, 2023 | 21.32M |
| March 31, 2023 | 7.065M |
| December 31, 2022 | 10.03M |
| September 30, 2022 | 17.51M |
| June 30, 2022 | 40.83M |
| March 31, 2022 | 48.81M |
| December 31, 2021 | 53.28M |
| September 30, 2021 | 61.50M |
| June 30, 2021 | 73.81M |
| Date | Value |
|---|---|
| March 31, 2021 | 74.99M |
| December 31, 2020 | 68.73M |
| September 30, 2020 | 61.47M |
| June 30, 2020 | 75.49M |
| March 31, 2020 | 74.15M |
| December 31, 2019 | 54.21M |
| September 30, 2019 | 35.98M |
| June 30, 2019 | 38.15M |
| March 31, 2019 | 37.03M |
| December 31, 2018 | 35.02M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |